Will Medicare Cover Wegovy? Current Guidance and What It Means for You
Most people with Medicare do not have Medicare Part D coverage of Wegovy for weight loss, because Medicare generally does not pay for weight-loss drugs except in people with both obesity and weight-related medical conditions, and only within a clinical trial or specific program. If you have Medicare Advantage, coverage may vary by plan and may require prior authorization and medical necessity criteria. This article explains how Medicare and Medicare Advantage typically handle GLP-1 receptor agonists like Wegovy, what to expect from medical necessity reviews, and practical steps you can take if you need help affording treatment.
Understanding Medicare Drug Coverage
Original Medicare (Parts A and B) covers medically necessary services but does not include a standard pharmacy benefit for outpatient prescription drugs. To get prescription drug coverage, most beneficiaries enroll in a standalone Medicare Part D plan or a Medicare Advantage plan that includes drug coverage (MA-PD). Whether a medication is covered—and how much you pay—depends on your plan’s formulary, which drugs are covered at each tier, and whether your prescriber and pharmacy are in-network.
Prior Authorization and Medical Necessity
Many plans require prior authorization for weight-loss medications, meaning the drug must be approved by the plan before you fill the prescription. Approval often depends on medical necessity, typically defined as having a BMI above a certain threshold and documented weight-related conditions such as type 2 diabetes or hypertension. Because Wegovy is a newer GLP-1 receptor agonist, plans may apply restrictive clinical criteria or require step-therapy trials of other interventions first.
Formulary Tiers and Cost Sharing
Formularies place drugs on tiers that determine your coinsurance or copay. GLP-1 receptor agonists are often on higher tiers with larger coinsurance amounts compared to preferred generics. Your cost sharing depends on whether you’ve met your deductible, whether you use a mail-order pharmacy or network pharmacy, and whether you reach the coverage gap (donut hole) or catastrophic coverage in Part D.
How Medicare Advantage Plans Handle Wegovy
Medicare Advantage (Part C) plans are required to offer at least the same level of drug coverage as Original Medicare, and many include enhanced benefits. Some Medicare Advantage plans may cover weight-loss medications like Wegovy under special programs, such as chronic condition management or supplemental benefits, though this varies widely by plan and regional contract. Prior authorization and medical necessity rules still apply, and some plans limit coverage to specific settings, such as enrollment in a diabetes or cardiovascular disease management program.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Standard Medicare Part D coverage of Wegovy | Generally not covered for weight loss except in limited circumstances, such as clinical trials | CMS and plan formulary guidance |
| Medicare Advantage drug coverage variability | Formularies and prior-authorization criteria differ by plan and region | Plan-specific member agreements and formulary files |
| Typical prior-authority requirements | Medical necessity criteria, BMI thresholds, and documented weight-related conditions; prior authorization often required | Common plan policy patterns |
| Cost-sharing placement | Often on higher formulary tiers with larger coinsurance; varies by plan phase (deductible, copay, coverage gap, catastrophic) | Formulary design and cost-sharing policies |
Medical Necessity and Prior Authorization Details
When a plan considers Wegovy medically necessary, it typically requires evidence such as documented obesity (BMI at or above the plan’s threshold, often 30 or higher, or 27 with comorbidities), prior attempts at lifestyle modification, and management of weight-related conditions. Prior authorization requests may include body-mass index, diagnosis codes, previous weight-loss efforts, and reasons why earlier interventions were insufficient. Plans may also require step therapy, meaning you try and fail certain lower-cost interventions before the plan will approve a higher-cost medication like Wegovy.
What to Gather Before Requesting Coverage
- Diagnosis codes related to obesity and comorbid conditions such as type 2 diabetes or hypertension
- Documented BMI measurements and previous weight-loss attempts, including dates and interventions
- Details of your current medications and any prior denials for weight-loss treatments
- Information from your provider about why Wegovy is medically necessary for your situation
Practical Steps if You Need Wegovy Under Medicare
If you think you might qualify for coverage, start with your plan’s pharmacy benefits handbook or online formulary tool to verify whether Wegovy or its generic alternative, if available, is listed and at what tier. Contact the number on the back of your member ID to discuss prior authorization, required documentation, and any plan-specific clinical criteria. Your healthcare provider can submit the medical justification, including BMI, diagnosis codes, and records of prior weight-loss efforts, to support the request. If your plan denies coverage, you can file an appeal and may explore disease-management programs or financial assistance options.
Alternatives and Financial Considerations
If Wegovy is not covered or is difficult to obtain, other options include discussing alternative medications that are on your plan’s preferred tier, enrolling in a Medicare-covered diabetes or heart disease program that may include GLP-1 therapy, or using manufacturer copay assistance if you are under the plan’s medical criteria but face high costs. Nonprofit programs and patient-support organizations sometimes help with co-pays or appeals. Compare the total expected costs, including premiums, deductibles, and coinsurance, against the overall benefit to determine whether a plan change or supplemental coverage makes sense for your needs.